Cilostazol on the Expression of ICAM‑1, VCAM-1and Inflammatory Factors in Plasma in Patients With Thromboangiitis Obliterans

Experimental and Therapeutic Medicine - Greece
doi 10.3892/etm.2018.6436
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Thromboangiitis Obliterans

Current Treatment Options in Rheumatology
RheumatologyAllergyImmunology
2016English

Thromboangiitis Obliterans

2016English

Thromboangiitis Obliterans

British Journal of Surgery
Surgery
1969English

Adrenoceptor Stimulation Does Not Affect ICAM-1 and VCAM-1 Expression in Vitro

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2011English

Thromboangiitis Obliterans

2016English

Thromboangiitis Obliterans

2013English

Levels of Soluble VCAM-1, Soluble ICAM-1, and Soluble E-Selectin in Patients With Tuberculous Pleuritis

Mediators of Inflammation
ImmunologyCell Biology
1996English

Thromboangiitis Obliterans (Buerger's Disease)

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2006English

Pyridinolcarbamate; Bradykinin Antagonist, in Patients Suffering From Arteriosclerosis Obliterans and Thromboangiitis Obliterans (Buerger's Disease)

Japanese Heart Journal
1965English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy